AzTrials
AzTrials

Chronic Respiratory FailurePhase 4NCT00698958

Ambulatory Adaptation to Non-Invasive Mechanical Ventilation

A Phase 4 study testing Ambulatory adaptation to non- invasive mechanical ventilation for 7 days and Hospital based adaptation to non- invasive mechanical ventilation for 7 days in people with Chronic Respiratory Failure, run by Hospital Clinic of Barcelona.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomised study to assess the effectiveness of ambulatory adaptation to non-invasive mechanical ventilation in patient with hypercapnic respiratory failure secondary to neuromuscular diseases or alterations in thoracic cage in comparison with hospital adaptation. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Chronic Respiratory Failure
What is being tested?
Ambulatory adaptation to non- invasive mechanical ventilation for 7 days and Hospital based adaptation to non- invasive mechanical ventilation for 7 days
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
No sites listed yet
Study dates
Jun 2003to not given
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 75
  • Chronic respiratory insufficiency secondary to neuromuscular disease or thoracic cage alterations with indication of non-invasive mechanical ventilation (presence of fatigue, dyspnea, morning headache, etc) plus one of the following criteria):
  • PaCO2 > 45 mmHg
  • Night time oxygen saturation < 88% at least for 5 consecutive minutes
  • In neuromuscular diseases, PIM < 60 cmH2O or FVC < 50% of theoretical.
  • Stable disease.
Show all 9Show fewer
  • Airway access through nasal mask.
  • Ability to provide written informed consent.
  • Ability to attend the visits

Who cannot join

  • Contraindications for mechanical ventilation:
  • Patient with terminal disease or vegetative state
  • Lack of motivation of the patient
  • Lack of family or social support
  • Patients clinically unstable
  • Agitation or lack of co-operation
Show all 12Show fewer
  • Depression.
  • Patients with acute symptoms requiring hospital admission.
  • Need for airway access through tracheostomy, face mask or mouth piece.
  • Relevant comorbidity (ie. heart failure, diabetes non controlled, infections, malignancies, etc.) leading to difficulties in adaptation to ventilation.
  • Use (for 7 days or more) of CNS depressors(benzodiazepines, antihistamines H1, tricyclic antidepressants , antiepileptic or antipsychotic drugs ) in the 30-day period prior to inclusion, or expected need for such drugs during the study.
  • Lack of understanding of the study procedures.

About this study

Official title: A Randomized Trial to Compare the Effectiveness of Hospital or Ambulatory Approach for Adaptation to Non-Invasive Mechanical Ventilation in Patients With Chronic Respiratory Failure Secondary to Neuromuscular Diseases or Thoracic Cage Alterations

A randomised study to assess the effectiveness of ambulatory adaptation to non-invasive mechanical ventilation in patient with hypercapnic respiratory failure secondary to neuromuscular diseases or alterations in thoracic cage in comparison with hospital adaptation.

Being tested
Ambulatory adaptation to non- invasive mechanical ventilation for 7 days, Hospital based adaptation to non- invasive mechanical ventilation for 7 days
Keywords
Respiratory insufficiency, Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage
Medical subject headings
Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ambulatory adaptation to non- invasive mechanical ventilation for 7 daysProcedure or surgery

    Ambulatory adaptation to non- invasive mechanical ventilation for 7 days

  • Hospital based adaptation to non- invasive mechanical ventilation for 7 daysProcedure or surgery

    Hospital based adaptation to non- invasive mechanical ventilation for 7 days

Study groups in NCT00698958
Study groupRoleWhat they receive
1Active comparatorHospital based adaptation to non- invasive mechanical ventilation for 7 days
Receives: Procedure: Hospital based adaptation to non- invasive mechanical ventilation for 7 days
2ExperimentalAmbulatory adaptation to non- invasive mechanical ventilation for 7 days
Receives: Procedure: Ambulatory adaptation to non- invasive mechanical ventilation for 7 days

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PaCO2 from baseline

    Measured: 6 months

Secondary outcomes (3)
  1. Change in PaCO2 from start of mechanical ventilation

  2. 6-minute walking test

  3. Adaptation failure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2008 (estimated)
  2. Study startJun 2003

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00698958
Sponsor's protocol ID
NEUMO/2002/01
Status last verified
Jun 2008
First submitted
13 Jun 2008
Last updated
17 Jun 2008
Results posted
No
Data monitoring committee
No

Publications

  • Pallero M, Puy C, Guell R, Pontes C, Marti S, Torres F, Anton A, Munoz X. Ambulatory adaptation to noninvasive ventilation in restrictive pulmonary disease: a randomized trial with cost assessment. Respir Med. 2014 Jul;108(7):1014-22. doi: 10.1016/j.rmed.2014.04.016. Epub 2014 May 2.

    PubMed 24837977

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Ambulatory adaptation to non- invasive mechanical ventilation for 7 days and Hospital based adaptation to non- invasive mechanical ventilation for 7 days in people with Chronic Respiratory Failure, run by Hospital Clinic of Barcelona.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jun 2008. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PaCO2 from baseline (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00698958, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in